New Jersey, Feb 07, 2022 - Freyr, one of the largest, global, Regulatory-focused solutions and services companies for the Life Sciences industry is pleased to announce its association with a fast-growing and…
February 2022
February 2022New Jersey, February 04, 2022 – Freyr is pleased to announce the successful MHRA registration process for 700 Medical Devices for an American medical device manufacturer domiciled in the UK and develops cardiac surgery and…
February 2022New Jersey – Feb 1, 2022: Freyr, one of the largest, global, Regulatory-focused solutions and services companies for the Life Sciences industry, recently announced that a Japanese Pharmaceutical Company (Global…
January 2022New Jersey, January 11, 2022: Freyr, a leading global Regulatory solutions and services provider supported a top American Multinational Pharmaceutical company for a US FDA Emergency Use Authorization (EUA) for a COVID-19…
December 2021New Jersey, December 17, 2021- Freyr is excited and elated to announce that it is bestowed with the “Best Supplier to the Industry” award by ELEMED for the year 2021. Represented by Vardhini S Krithivas – Head of Global Medical…
December 2021New Jersey, December 13, 2021 - Freyr Solutions, announces successful submission of a complex Application to the Drugs Controller General of India (DCGI). The submission was made through an online portal – SUGAM – of the CDCSO,…
ACQ5 Honored Freyr with Three “Gamechangers 2021 Global Awards” in the Pharma and Lifesciences Space
December 2021New Jersey, December 01, 2021 – Freyr Solutions, a leading global Regulatory solutions and services provider, got rewarded in three (03) categories in the “ACQ5 Gamechangers 2021 Global Awards”, namely, International – Regulatory…
September 2021New Jersey, September 23, 2021- Freyr, a leading global Regulatory solutions and services provider, is pleased to announce the feat of completing 40+ Permitted Daily Exposure (PDE) reports for a multi-national pharmaceutical…
September 2021New Jersey, September 2, 2021 – Freyr Solutions, a leading global Regulatory solutions and services provider, has been honored for ‘Innovative Global Regulatory Services and Solutions for Life Sciences’ by the GHP (Global Health…
May 2021New Jersey, May 18, 2021- Freyr, a leading global Regulatory solutions and services provider, is pleased to announce the feat of completing 1500+ Permissible Daily Exposure (PDE) reports. The feat has been achieved within three (…
November 2020New Jersey – November 11, 2020: Freyr, a leading global Regulatory solutions and services provider, announced successful submission and approval of a New Dietary Ingredient Notification (NDIN) to the United States Food and Drug…
October 2020Princeton, NJ - October 29, 2020: Freyr solutions, a leading global Regulatory solutions and services provider announces successful completion of its first Structured Product Monograph (SPM) submission to Health Canada (HC). The…